HEAD AND NECK-CANCER - DETECTION OF RECURRENCE WITH PET AND 2-[F-18]FLUORO-2-DEOXY-D-GLUCOSE

被引:138
作者
LAPELA, M
GRENMAN, R
KURKI, T
JOENSUU, H
LESKINEN, S
LINDHOLM, P
HAAPARANTA, M
RUOTSALAINEN, U
MINN, H
机构
[1] UNIV TURKU,CENT HOSP,DEPT OTORHINOLARYNGOL,SF-20520 TURKU,FINLAND
[2] UNIV TURKU,CENT HOSP,CTR MED IMAGING,SF-20520 TURKU,FINLAND
[3] HELSINKI UNIV,DEPT ONCOL,HELSINKI,FINLAND
[4] TURKU UNIV,CTR CYCLOTRON PET,SF-20520 TURKU,FINLAND
关键词
HEAD AND NECK NEOPLASMS; DIAGNOSIS; EMISSION CT (ECT);
D O I
10.1148/radiology.197.1.7568825
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To evaluate positron emission tomography (PET) with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) in detection of suspected recurrence of head and neck cancer, and to compare visual, static, and kinetic analyses of the tracer uptake. MATERIALS AND METHODS: Seventeen dynamic FDG PET studies were performed in 15 patients. The images were interpreted visually, and the uptake was quantitated as the standardized uptake value (SUV) and as the regional FDG metabolic rate. RESULTS: Sensitivity of blinded visual interpretation of the PET images for the presence of malignancy was 88% and specificity was 86%. Malignant lesions accumulated significantly more FDG than benign lesions (P = .008 for SUVs, P = .002 for regional metabolic rates). When maximum uptake of FDG in the benign lesions was used as a threshold, the sensitivity of SUV analysis for malignancy was 75% and that of regional metabolic rates was 86%. CONCLUSION: Detection of recurrent head and neck cancer is feasible with FDG PET. Quantitation of FDG uptake assists in correct interpretation of the PET images.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 45 条
[1]  
BRONSTEIN AD, 1989, AM J NEURORADIOL, V10, P171
[2]   POSITRON EMISSION TOMOGRAPHY WITH FLUORODEOXYGLUCOSE TO EVALUATE TUMOR RESPONSE AND CONTROL AFTER RADIATION-THERAPY [J].
CHAIKEN, L ;
REGE, S ;
HOH, C ;
CHOI, Y ;
JABOUR, B ;
JUILLARD, G ;
HAWKINS, R ;
PARKER, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (02) :455-464
[3]   CEREBRAL NECROSIS AFTER RADIOTHERAPY AND OR INTRAARTERIAL CHEMOTHERAPY FOR BRAIN-TUMORS - PET AND NEUROPATHOLOGIC STUDIES [J].
DICHIRO, G ;
OLDFIELD, E ;
WRIGHT, DC ;
DEMICHELE, D ;
KATZ, DA ;
PATRONAS, NJ ;
DOPPMAN, JL ;
LARSON, SM ;
ITO, M ;
KUFTA, CV .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1988, 150 (01) :189-197
[4]   THE NECK AFTER TOTAL LARYNGECTOMY - CT STUDY [J].
DISANTIS, DJ ;
BALFE, DM ;
HAYDEN, RE ;
SAGEL, SS ;
SESSIONS, D ;
LEE, JKT .
RADIOLOGY, 1984, 153 (03) :713-717
[5]   NECK NEOPLASMS - MR IMAGING .2. POSTTREATMENT EVALUATION [J].
GLAZER, HS ;
NIEMEYER, JH ;
BALFE, DM ;
HAYDEN, RE ;
EMAMI, B ;
DEVINENI, VR ;
LEVITT, RG ;
ARONBERG, DJ ;
WARD, MP ;
LEE, JKT ;
SAGEL, SS .
RADIOLOGY, 1986, 160 (02) :349-354
[6]   DISTINGUISHING TUMOR RECURRENCE FROM IRRADIATION SEQUELAE WITH POSITRON EMISSION TOMOGRAPHY IN PATIENTS TREATED FOR LARYNX CANCER [J].
GREVEN, KM ;
WILLIAMS, DW ;
KEYES, JW ;
MCGUIRT, WF ;
HARKNESS, BA ;
WATSON, NE ;
RABEN, M ;
FRAZIER, LC ;
GEISINGER, KR ;
CAPPELLARI, JO .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 29 (04) :841-845
[7]  
GREVEN KM, 1994, CANCER, V74, P1355, DOI 10.1002/1097-0142(19940815)74:4<1355::AID-CNCR2820740428>3.0.CO
[8]  
2-I
[9]  
HABERKORN U, 1991, J NUCL MED, V32, P1548
[10]  
HABERKORN U, 1991, J NUCL MED, V32, P1485